These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35429948)

  • 41. International trends in cancer incidence in middle-aged and older adults in 44 countries.
    Pilleron S; Alqurini N; Ferlay J; Haase KR; Hannan M; Janssen-Heijnen M; Kantilal K; Katanoda K; Kenis C; Lu-Yao G; Matsuda T; Navarrete E; Nikita N; Puts M; Strohschein FJ; Morris EJA
    J Geriatr Oncol; 2022 Apr; 13(3):346-355. PubMed ID: 34866023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gynaecological cancer incidence and mortality trends in a Brazilian State with medium human development index: A 22-year analysis.
    da Silva BEB; de Lemos LMD; Moura AR; Ferrari YAC; Lima MS; Santos MO; Lima CA
    Cancer Epidemiol; 2024 Feb; 88():102493. PubMed ID: 38056244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers.
    Ganmaa D; Sato A
    Med Hypotheses; 2005; 65(6):1028-37. PubMed ID: 16125328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999-2020.
    Cho S; Park WJ
    Investig Clin Urol; 2024 Jan; 65(1):23-31. PubMed ID: 38197748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. National and Subnational Trends of Incidence and Mortality of Female Genital Cancers in Iran; 1990-2016.
    Eftekharzadeh S; Ebrahimi N; Samaei M; Mohebi F; Mohajer B; Sheidaei A; Gohari K; Saeedi Moghaddam S; Ahmadi N; Mohammadi Fateh S; Ramezani Tehrani F; Farzadfar F
    Arch Iran Med; 2020 Jul; 23(7):434-444. PubMed ID: 32657594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Burden of breast and gynecological cancers in Tunisia between 1990 and 2030: Trend and projection.
    Dhaouadi S; Cherif A; Hannachi H; Osman M; Hsairi M
    Tunis Med; 2021 Avril; 99(4):390-398. PubMed ID: 35244922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
    Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
    BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative survival analysis of gynecological cancers in an urban district of Shanghai during 2002-2013.
    Jiang YF; Jiang Y; Bi JH; Zhang Y; Zheng WW; Zhou XH; Wu J; Yuan HY; Zhao WS; Xiang YB
    Cancer Epidemiol; 2023 Jun; 84():102355. PubMed ID: 36989956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The incidence of female breast and genital cancer: analysis of the age-dependence.
    Dix D; Cohen P; Barzegar S
    Anticancer Res; 1983; 3(4):251-5. PubMed ID: 6881922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women.
    Shin HR; Joubert C; Boniol M; Hery C; Ahn SH; Won YJ; Nishino Y; Sobue T; Chen CJ; You SL; Mirasol-Lumague MR; Law SC; Mang O; Xiang YB; Chia KS; Rattanamongkolgul S; Chen JG; Curado MP; Autier P
    Cancer Causes Control; 2010 Nov; 21(11):1777-85. PubMed ID: 20559704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence distributions, risk factors and trends of vaginal cancer: A global population-based study.
    Huang J; Chan SC; Pang WS; Mak FY; Fung YC; Lok V; Zhang L; Lin X; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
    BJOG; 2024 Nov; 131(12):1660-1672. PubMed ID: 38924674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Global pattern and trend of cervical cancer incidence from 1993 to 2012: Joinpoint regression and age-period-cohort analysis.
    Krishnamoorthy Y; Rajaa S; Giriyappa DK
    Indian J Cancer; 2022; 59(4):521-531. PubMed ID: 34380829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland, 1971-1995).
    Pukkala E; Weiderpass E
    Int J Cancer; 1999 Mar; 81(1):56-61. PubMed ID: 10077153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?
    Ghiasvand R; Adami HO; Harirchi I; Akrami R; Zendehdel K
    BMC Cancer; 2014 May; 14():343. PubMed ID: 24884841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
    Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
    Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study.
    Singh M; Jha RP; Shri N; Bhattacharyya K; Patel P; Dhamnetiya D
    BMC Cancer; 2022 Feb; 22(1):149. PubMed ID: 35130853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in Breast Cancer Incidence in Iraq During the Period 2000-2019.
    Al-Hashimi MMY
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3889-3896. PubMed ID: 34967568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations.
    Schneider C; Jick SS; Meier CR
    Climacteric; 2009 Dec; 12(6):514-24. PubMed ID: 19905903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Gynecological and breast cancer in the department of Somme].
    Peng J; Raverdy N; Foulques H; Verhoest P; Thulliez A; Lorriaux A; Dubreuil A
    Rev Epidemiol Sante Publique; 2004 Oct; 52(5):423-30. PubMed ID: 15654312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent trends in incidence, mortality and survival after cancer of the female breast and reproductive organs. Umbria, Italy: 1978-2005.
    D'alò D; Stracci F; Cassetti T; Scheibel M; Pascucci C; La Rosa F
    Eur J Gynaecol Oncol; 2010; 31(2):174-80. PubMed ID: 20527234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.